US Stock MarketDetailed Quotes

ORGO Organogenesis

Watchlist

4.880
0.0000.00%

Close Mar 21 16:00 ET

4.920
+0.040+0.82%

Post 20:01 ET

618.92MMarket Cap-488.00P/E (TTM)

Organogenesis Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Organogenesis Q4 2024 Earnings Date

Currency：USDFeb 27, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	109.60M	126.66M	+17.06M
Beat Est.	+9.98%	+27.10%	+15.56%
EPS	-0.01	0.04	+0.05
Beat Est.	--	+1021.87%	+368.46%

Analyst Rating

Strong Buy

Mar 5, 2025

Organogenesis Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 102.167M	--
--	2025/Q1	-- / 90.767M	--
Feb 27, 2025	2024/Q4	126.656M / 109.600M	--
Nov 12, 2024	2024/Q3	115.177M / 109.467M	--
Aug 8, 2024	2024/Q2	130.234M / 121.300M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 102.167M--

--2025/Q1-- / 90.767M--

Feb 27, 20252024/Q4126.656M / 109.600M--

Nov 12, 20242024/Q3115.177M / 109.467M--

Aug 8, 20242024/Q2130.234M / 121.300M--

Unlock Free Earnings Estimates

Open Account

Organogenesis Earnings Reports

Organogenesis | 10-K: FY2024 Annual Report

Feb 27 16:31 ET

Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results

Feb 27 16:05 ET

Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results

Nov 12, 2024 16:42 ET

Organogenesis | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 16:22 ET